Christopher J. Lafargue

3.9k total citations · 1 hit paper
30 papers, 1.8k citations indexed

About

Christopher J. Lafargue is a scholar working on Molecular Biology, Surgery and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Christopher J. Lafargue has authored 30 papers receiving a total of 1.8k indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Molecular Biology, 9 papers in Surgery and 9 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Christopher J. Lafargue's work include Ovarian cancer diagnosis and treatment (7 papers), Endometrial and Cervical Cancer Treatments (6 papers) and Prostate Cancer Treatment and Research (6 papers). Christopher J. Lafargue is often cited by papers focused on Ovarian cancer diagnosis and treatment (7 papers), Endometrial and Cervical Cancer Treatments (6 papers) and Prostate Cancer Treatment and Research (6 papers). Christopher J. Lafargue collaborates with scholars based in United States, Germany and Switzerland. Christopher J. Lafargue's co-authors include Mark A. Rubin, Anil K. Sood, Robert L. Coleman, Graziela Zibetti Dal Molin, Francesca Demichelis, Sven Perner, Raquel Esgueva, Rameen Beroukhim, Jayoung Kim and Dolores Di Vizio and has published in prestigious journals such as Cancer Research, The Lancet Oncology and The Journal of Pathology.

In The Last Decade

Christopher J. Lafargue

29 papers receiving 1.8k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Exploring and comparing adverse events between PARP inhibitors

2019 346 citations Christopher J. Lafargue, Graziela Zibetti Dal Molin et al. The Lancet Oncology profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Christopher J. Lafargue United States	16	947	825	640	567	142	30	1.8k
Joshua Armenia United States	18	841 0.9×	412 0.5×	680 1.1×	512 0.9×	169 1.2×	35	1.6k
Sunita R. Setlur United States	15	1.0k 1.1×	1.1k 1.3×	327 0.5×	637 1.1×	76 0.5×	22	2.0k
Brian P. Adley United States	22	724 0.8×	405 0.5×	347 0.5×	313 0.6×	242 1.7×	30	1.5k
Jari Sundström Finland	22	484 0.5×	295 0.4×	520 0.8×	332 0.6×	151 1.1×	49	1.2k
Maja J.A. de Jonge Netherlands	19	865 0.9×	420 0.5×	848 1.3×	259 0.5×	125 0.9×	40	1.6k
Richard Letrero United States	10	976 1.0×	297 0.4×	417 0.7×	366 0.6×	257 1.8×	12	1.3k
Gillian Ellison United Kingdom	13	620 0.7×	1.0k 1.2×	924 1.4×	630 1.1×	73 0.5×	20	1.7k
Heidrun Gevensleben Germany	27	954 1.0×	639 0.8×	904 1.4×	537 0.9×	187 1.3×	56	2.1k
Douglas I. Lin United States	26	1.4k 1.5×	916 1.1×	1.0k 1.6×	417 0.7×	299 2.1×	112	2.6k
Jon Chung United States	25	765 0.8×	720 0.9×	1.0k 1.6×	677 1.2×	424 3.0×	109	2.0k

Countries citing papers authored by Christopher J. Lafargue

Since Specialization

Citations

This map shows the geographic impact of Christopher J. Lafargue's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Christopher J. Lafargue with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Christopher J. Lafargue more than expected).

Fields of papers citing papers by Christopher J. Lafargue

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Christopher J. Lafargue. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Christopher J. Lafargue. The network helps show where Christopher J. Lafargue may publish in the future.

Co-authorship network of co-authors of Christopher J. Lafargue

This figure shows the co-authorship network connecting the top 25 collaborators of Christopher J. Lafargue. A scholar is included among the top collaborators of Christopher J. Lafargue based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Christopher J. Lafargue. Christopher J. Lafargue is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Lafargue, Christopher J., Nicole D. Fleming, Alpa M. Nick, et al.. (2022). Clinical analysis of pathologic complete responders in advanced-stage ovarian cancer. Gynecologic Oncology. 165(1). 82–89. 5 indexed citations

Lafargue, Christopher J., Graziela Zibetti Dal Molin, Anil K. Sood, & Robert L. Coleman. (2019). Exploring and comparing adverse events between PARP inhibitors. The Lancet Oncology. 20(1). e15–e28. 346 indexed citations breakdown →

Hinchcliff, Emily, et al.. (2019). Poly-ADP-ribose polymerase inhibitor use in ovarian cancer: expanding indications and novel combination strategies. International Journal of Gynecological Cancer. 29(5). 956–968. 3 indexed citations

Villar‐Prados, Alejandro, Sherry Y. Wu, Karem A. Court, et al.. (2018). Predicting Novel Therapies and Targets: Regulation of Notch3 by the Bromodomain Protein BRD4. Molecular Cancer Therapeutics. 18(2). 421–436. 10 indexed citations

Lara, Olivia D., Cristian Rodriguez‐Aguayo, Emine Bayraktar, et al.. (2018). Grabbing the Grb2/GAB2 complex in ovarian cancer. Gynecologic Oncology. 149. 60–60. 2 indexed citations

Gharpure, Kshipra M., Olivia D. Lara, Yunfei Wen, et al.. (2018). ADH1B promotes mesothelial clearance and ovarian cancer infiltration. Oncotarget. 9(38). 25115–25126. 23 indexed citations

Lafargue, Christopher J., et al.. (2016). Short-term morbidity in transdiaphragmatic cardiophrenic lymph node resection for advanced stage gynecologic cancer. Gynecologic Oncology Reports. 17. 33–37. 19 indexed citations

Lafargue, Christopher J. & Krishnansu S. Tewari. (2016). Recent Patents for Homologous Recombination Deficiency Assays Among Women with Ovarian Cancer. Recent Patents on Biotechnology. 9(2). 86–101.

Lafargue, Christopher J. & Robert E. Bristow. (2015). Transdiaphragmatic cardiophrenic lymph node resection for Stage IV ovarian cancer. Gynecologic Oncology. 138(3). 762–763. 11 indexed citations

10.

Lafargue, Christopher J., Fong Liu, Leslie M. Randall, & Robert E. Bristow. (2015). Transdiaphragmatic cardiophrenic lymph node dissection in advanced stage gynecologic cancer. Gynecologic Oncology. 139(1). 194–195. 1 indexed citations

11.

Nguyen, My-Linh T., et al.. (2013). Grade 1 Endometrioid Endometrial Carcinoma Presenting with Pelvic Bone Metastasis: A Case Report and Review of the Literature. Case Reports in Obstetrics and Gynecology. 2013. 1–3. 7 indexed citations

12.

Esgueva, Raquel, Sven Perner, Christopher J. Lafargue, et al.. (2010). Prevalence of TMPRSS2–ERG and SLC45A3–ERG gene fusions in a large prostatectomy cohort. Modern Pathology. 23(4). 539–546. 121 indexed citations

13.

Magi‐Galluzzi, Cristina, Paul Elson, Kelly Simmerman, et al.. (2010). TMPRSS2–ERG gene fusion prevalence and class are significantly different in prostate cancer of caucasian, african‐american and japanese patients. The Prostate. 71(5). 489–497. 200 indexed citations

14.

Rickman, David S., Ying‐Bei Chen, Samprit Banerjee, et al.. (2010). ERG Cooperates with Androgen Receptor in Regulating Trefoil Factor 3 in Prostate Cancer Disease Progression. Neoplasia. 12(12). 1031–IN22. 46 indexed citations

15.

Svensson, Maria A., Christopher J. Lafargue, Theresa Y. MacDonald, et al.. (2010). Testing mutual exclusivity of ETS rearranged prostate cancer. Laboratory Investigation. 91(3). 404–412. 58 indexed citations

16.

Vizio, Dolores Di, Jayoung Kim, Martin H. Hager, et al.. (2009). Oncosome Formation in Prostate Cancer: Association with a Region of Frequent Chromosomal Deletion in Metastatic Disease. Cancer Research. 69(13). 5601–5609. 334 indexed citations

17.

Pflueger, Dorothee, David S. Rickman, Andrea Sboner, et al.. (2009). N-myc Downstream Regulated Gene 1 (NDRG1) Is Fused to ERG in Prostate Cancer. Neoplasia. 11(8). 804–W18. 98 indexed citations

18.

Perner, Sven, Patrick Wagner, Francesca Demichelis, et al.. (2008). EML4-ALK Fusion Lung Cancer: A Rare Acquired Event. Neoplasia. 10(3). 298–302. 196 indexed citations

19.

Prades, Catherine, Isabelle Arnould, Tarmo Annilo, et al.. (2002). The human ATP binding cassette gene ABCA13, located on chromosome 7p12.3, encodes a 5058 amino acid protein with an extracellular domain encoded in part by a 4.8-kb conserved exon. Cytogenetic and Genome Research. 98(2-3). 160–168. 30 indexed citations

20.

Broccardo, Cyril, José Osorio, M F Luciani, et al.. (2001). Comparative analysis of the promoter structure and genomic organization of the human and mouse ABCA7 gene encoding a novel ABCA transporter. Cytogenetic and Genome Research. 92(3-4). 264–270. 39 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact